Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Corcept Therapeutics (CORT)

$10.36 0.05 (0.48%)

16:23 EDT CORT Stock Quote Delayed 15 Minutes

Volume:

Previous Close $10.36

Market Cap 1.19B

PE Ratio 9.09

EPS 1.14

Volume (Avg. Vol.) 375,700

Day's Range 10.30 - 10.44

52-Week Range 9.14 - 19.56

Dividend & Yield N/A (N/A)

CORT Stock Predictions, Articles, and Corcept Therapeutics News

From InvestorPlace
From the Web

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

By Karl Utermohlen, InvestorPlace Writer May 18, 2018

The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.

10 Healthcare Stocks to Stave Off the Market Flu

By Louis Navellier, Editor, Growth Investor Apr 6, 2018

One thing is certain, healthcare isn’t going away.

Plains GP Holdings LP (PAGP) and Green Plains Inc (GPRE) Lead Today’s Top 11 Investor Filings

By Fintel Jun 15, 2017

13D and 13G filings are windows on activist investor activity. Today we focus on Plains GP Holdings LP, Green Plains Inc and 9 other filings

7 Healthcare Stocks With A-Rated Prospects

By Louis Navellier, Editor, Growth Investor Apr 21, 2017

An Obamacare replacement is back in the news, and these seven A-rated healthcare stocks are winners regardless of how it shakes out.

Sun files for generic version of Corcept's Korlym

From Seeking Alpha Jun 11, 2019

Corcept Therapeutics (NASDAQ:CORT) reports that it has received notice that Sun Pharmaceutical Industries Limited has submitted a U.S. marketing application for a generic version of KORLYM (mifepristo

The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace

From Benzinga Jun 1, 2019

Biotech stocks came under pressure this week ahead of the ASCO 2019 presentations. Headlines on legal woes related to the opioid crisis and drug price manipulation led to...

Oversold Conditions For Corcept Therapeutics (CORT)

From Market News Video May 22, 2019

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

First Week of CORT July 19th Options Trading

From Market News Video May 21, 2019

Investors in Corcept Therapeutics Inc (CORT) saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

Corcept Therapeutics Incorporated (CORT) Q1 2019 Earnings Call Transcript

From The Motley Fool May 10, 2019

CORT earnings call for the period ending March 31, 2019.

Corcept Therapeutics beats by $0.01, misses on revenue

From Seeking Alpha May 9, 2019

Corcept Therapeutics (NASDAQ:CORT): Q1 Non-GAAP EPS of $0.20 beats by $0.01; GAAP EPS of $0.15 misses by $0.04.Revenue of $64.83M (+12.4% Y/Y) misses by $4.46M.Press Release

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!